Search Results - "Nordlander, M"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery by Powroznyk, A V V, Vuylsteke, A, Naughton, C, Misso, S L, Holloway, J, Jolin-Mellgård, A, Latimer, R D, Nordlander, M, Feneck, R O

    Published in European journal of anaesthesiology (01-09-2003)
    “…We set out to compare the efficacy of clevidipine and sodium nitroprusside infusions in the control of blood pressure and the haemodynamic changes they produce…”
    Get more information
    Journal Article
  5. 5

    The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectoris by Gullestad, L., Bjurø, T., Aaberge, L., Apelland, T., Skårdal, R., Kjekshus, E., Nordlander, M., Åblad, B., Pernow, J.

    Published in European heart journal (01-06-2003)
    “…Aims Neuropeptide Y (NPY) is a potent vasoconstrictor released during sympathetic activation that may be involved in myocardial ischaemia. We examined the…”
    Get full text
    Journal Article
  6. 6

    Clinical and pharmacokinetic results with a new ultrashort‐acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers by ERICSSON, H, FAKT, C, JOLIN-MELLGARD, A, NORDLANDER, M, SOHTELL, L, SUNZEL, M, REGARDH, C. G

    Published in British journal of clinical pharmacology (01-05-1999)
    “…Aims To investigate the tolerability and safety of clevidipine in healthy male volunteers during intravenous infusion at gradually increasing dose rates and to…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Pharmacokinetics of New Calcium Channel Antagonist Clevidipine in the Rat, Rabbit, and Dog and Pharmacokinetic/Pharmacodynamic Relationship in Anesthetized Dogs by ERICSSON, H, THOLANDER, B, BJÖRKMAN, J. A, NORDLANDER, M, REGARDH, C. G

    Published in Drug metabolism and disposition (01-05-1999)
    “…Clevidipine is a new vascular selective calcium channel antagonist of the dihydropyridine type, structurally related to felodipine. Clinical trials have shown…”
    Get full text
    Journal Article
  8. 8

    Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery by Kieler-Jensen, N., Jolin-Mellgård, Å., Nordlander, M., Ricksten, S.-E.

    Published in Acta anaesthesiologica Scandinavica (01-02-2000)
    “…Background: The aim was to evaluate the use of clevidipine, a new vascular selective, ultra‐short‐acting calcium antagonist for blood pressure control after…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion by ERICSSON, H, FAKT, C, HÖGLUND, L, JOLIN-MELLGARD, A, NORDLANDER, M, SUNZEL, M, REGARDH, C. G

    Published in European journal of clinical pharmacology (01-03-1999)
    “…To determine the pharmacokinetics and pharmacodynamics of clevidipine, a new ultrashort-acting calcium antagonist, in healthy male volunteers following a…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass by Vuylsteke, A., Milner, Q., Ericsson, H., Mur, D., Dunning, J., Jolin-Mellgård, Å., Nordlander, M., Latimer, R.

    Published in British journal of anaesthesia : BJA (01-11-2000)
    “…Clevidipine is a new vascular-selective, calcium channel antagonist of the dihydropyridine type with an ester side chain susceptible to esterase metabolism. In…”
    Get full text
    Journal Article
  11. 11

    Perioperative blood pressure control: A prospective survey of patient management in cardiac surgery by Vuylsteke, Alain, Feneck, Robert O., Jolin-Mellgård, Åse, Latimer, Raymond D., Levy, Jerrold H., Lynch, Carl, Nordlander, Margareta L., Nyström, Per, Ricksten, Sven-Erik

    “…Objective To conduct a survey of current cardiac anesthetic practice in Europe and the United States, as a first step toward establishing guidelines for the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Effects of chronic felodipine treatment on renal function and morphology in SHR by Nordlander, M, Havu, N

    Published in Kidney international. Supplement (01-05-1992)
    “…To investigate if blood pressure reduction per se may prevent progressive renal disease in aging spontaneously hypertensive rats (SHR), 15-month-old SHR were…”
    Get more information
    Journal Article
  14. 14

    Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance by Cheng, C P, Noda, T, Nordlander, M, Ohno, M, Little, W C

    “…We compared the effects of three dihydropyridine calcium antagonists (felodipine, nifedipine and amlodipine) on left ventricular (LV) contractile performance…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Renal effects of felodipine--a review by Elmfeldt, D, Nordlander, M, Edgar, B

    Published in Kidney international. Supplement (01-05-1992)
    “…Felodipine is a dihydropyridine calcium antagonist which lowers total peripheral resistance and blood pressure in doses which have no effect on cardiac…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Inhibition of vascular myogenic tone and reactivity by calcium antagonists by Nordlander, M I

    Published in Journal of hypertension. Supplement (01-09-1989)
    “…In most organs basal vascular tone is maintained by the myogenic tone in the smooth muscles of the resistance vessels. Commonly used antihypertensive calcium…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Pharmacodynamic properties of felodipine by Ljung, B, Nordlander, M

    Published in Drugs (New York, N.Y.) (1987)
    “…This overview presents the pharmacodynamic properties of felodipine as studied in animal experiments with emphasis on results from our laboratory. Felodipine…”
    Get full text
    Journal Article